TS222456294	mealTime 11 15	meal
TS1722456294	treatedDisease 129 144	Type 2 diabetes
TS1222456294	mealTime 172 176	meal
TS2722456294	drug 236 279	dipeptidyl peptidase IV ( DPP-4 ) inhibitor
TS422456294	treatedDisease 319 334	Type 2 diabetes
TS1822456294	treatedDisease 416 431	Type 2 diabetes
TS522456294	drug 931 943	Vildagliptin
TS2022456294	mealTime 1004 1008	meal
TS2422456294	mealTime 1120 1124	Meal
TS722456294	drugEffect 1253 1300	active glucagon-like peptide-1 levels increased
TS1422456294	drugEffect 1328 1410	Fasting plasma glucose ( FPG ) and postprandial plasma glucose ( PPPG ) reductions
TS122456294	mealTime 1459 1463	meal
TS1022456294	mealTime 1666 1671	meals
TS1622456294	sideeffect 1763 1778	Type 2 diabetes
T1	drug 90 102	vildagliptin
R1	treat Arg1:T1 Arg2:TS1722456294	
T2	drug 280 292	vildagliptin
R2	treat Arg1:TS2722456294 Arg2:TS422456294	
R3	treat Arg1:T2 Arg2:TS422456294	
T3	frequency 451 462	twice-daily
T4	drug 463 475	vildagliptin
T5	dosage 476 481	50 mg
R4	treat Arg1:T4 Arg2:TS1822456294	
T6	mealTime 497 510;533 542;547 553	30 min before breakfast dinner
T7	mealTime 514 542;547 553	immediately before breakfast dinner
T8	duration 554 564	for 7 days
T9	drug 690 702	vildagliptin
T10	drug 761 773	Vildagliptin
T11	mealTime 819 832;864 869	30 min before meals
R5	slow_absorption Arg1:T11 Arg2:T10	
T12	mealTime 845 869	immediately before meals
T13	drugEffect 1175 1191	DPP-4 inhibition
R6	no_effect_on_drug Arg1:TS122456294 Arg2:TS1422456294	
T14	drug 1595 1607	Vildagliptin
T15	mealTime 1665 1670	meals
T16	drug 1686 1698	vildagliptin
T17	treatedDisease 1762 1777	Type 2 diabetes
R7	treat Arg1:T16 Arg2:T17	
R8	no_effect_on_drug Arg1:T15 Arg2:T16	
